PDZ and LIM Domain 2 (PDLIM2) (N-Term) Peptid
PDLIM2
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle PDLIM2 Produkte
- PDLIM2 (PDZ and LIM Domain 2 (PDLIM2))
- Protein Region
- N-Term
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Sequenz
- LHAEAQSKIR QSPSPLRLQL DRSQATSPGQ TNGDSSLEVL ATRFQGSVRT
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-PDLI2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- PDLIM2 (PDZ and LIM Domain 2 (PDLIM2))
- Hintergrund
-
This gene encodes a member of the ALP subfamily of PDZ-LIM domain proteins. The encoded protein suppresses anchorage-dependent growth and promotes cell migration and adhesion through interactions with the actin cytoskeleton via the PDZ domain. The encoded protein is also a putative tumor suppressor protein, and decreased expression of this gene is associated with several malignancies including breast cancer and adult T-cell leukemia. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene.
Alias Symbols: PDLIM2,PP6345,
Protein Size: 352 - Gen-ID
- 64236
- UniProt
- Q96JY6
-
Sie sind hier:
